dosage l-carnitine Characteristics of included studies Maxler L Carnitine Liquid High

Abbreviations 2,2-BP 2,2-bipyridyl 4-HNE 4-hydroxynonenal AA arachidonic acid ACSL4 acyl-CoA synthetase long chain family member 4 AdA adrenoyl ALOX arachidonate lipoxygenase BHT butylated hydroxytoluene BSO buthionine sulfoximine CCI 4 carbon tetrachloride CCCP carbonyl cyanide m-chlorophenyl hydrazine c-di-AMP cyclic-di-adenosine monophosphate CIL56 caspase-independent lethal 56 CoQ 10 coenzyme Q 10 COX cyclooxygenase CYP cytochrome p450 DPI diverse pharmacological inhibitor D-PUFA deuterated polyunsaturated fatty acid EMC endoplasmic reticulum membrane protein complex ER endoplasmic reticulum ERAD endoplasmic reticulumassociated protein degradation ERO1 endoplasmic reticulum oxidoreduction-1 FAD flavin adenine dinucleotide FAM134B family with sequence similarity 134 member B Fer-1 ferrostatin-1 FIN56 ferroptosis inducer 56 FINO 2 ferroptosis inducer endoperoxide GPX4 glutathione peroxidase 4 GSH glutathione GSSG glutathione disulfide HMG-CoA -hydroxy -methylglutaryl-CoA HPETE hydroperoxyeicosatetraenoic acid IKE imidazole ketone erastin LOOH lipid hydroperoxide LOX lipoxygenase LPCAT3 lysophosphatidylcholine acyltransferase 3 MDA malondialdehyde MEF mouse embryonic fibroblasts ML162 Molecular Libraries 162 mTOR mechanistic target of rapamycin NCCD Nomenclature Committee on Cell Death PDI protein disulfide isomerase PE piperazine erastin PHKG2 phosphorylase b kinase 2 PPAR peroxisome proliferator-activated receptor PUFA polyunsaturated fatty acid PUFA-PL polyunsaturated-fatty-acid-containing phospholipid ROS reactive oxygen species RSL3 RAS-selective lethal 3 RTN3 reticulon-3 SQS squalene synthase STING stimulator of interferon genes UPR unfolded protein response Funding Statement National Cancer Institute (grant number 1R35CA209896)

A glass-based, continuously zonated and vascularized human liver acinus microphysiological system (vLAMPS) designed for experimental modeling of diseases and ADME/TOX

& Houssin, D

Hence, the treatment with rhamnetin was observed to slow down the metabolic clearance of sorafenib in HCC cells, and this effect was correlated with the expression of miR-148a